I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Rundu Pharma announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, involving the drug: Valsartan and Amlodipine Tablets (I). This product is suitable for the treatment of primary hypertension. It is used for patients whose blood pressure cannot be adequately controlled with monotherapy
According to the Zhitong Finance APP, Rundu Pharma (002923.SZ) announced that it recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, involving the drug: Valsartan and Amlodipine Tablets (I). This product is suitable for the treatment of primary hypertension. It is used for patients whose blood pressure cannot be adequately controlled with monotherapy